Home | Survey | Payment| Talks & Presentations | Job Opportunities
Journals   A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Journal of China Pharmaceutical University
1000-5048
2016 Issue 1
Research progress of Polo-like kinase 1 inhibitors targeting Polo-box domain
YAO Aihong;CHANG Yujie;JIANG Cheng;SUN Haiying;Key Laboratory of Drug Design and Optimization of Jiangsu Province;School of Pharmacy;China Pharmaceutical University;
..............page:1-8
PD-1/PD-Ls signaling pathway and the application of anti-PD-1/PD-Ls antibodies in cancer therapy
PAN Jiajia;JIA Xiaoqing;HUANG Gang;ZHANG Yubin;School of Life Science & Technology;China Pharmaceutical University;
..............page:9-18
Advances in enrichment strategies for phosphoproteomics and its application in the research of disease
WU Weixin;YAN Jia;TAN Xiying;LI Bo;SU Mengxiang;YAN Fang;DI Bin;Department of Pharmaceutical Analysis;China Pharmaceutical University;Key Laboratory of Drug Quality Control and Pharmacovigilance;Ministry of Education;Research Division of Clinical Pharmacy;Jiangsu Provincial Hospital of Tranditional Chinese Medicine;
..............page:19-29
Synthesis and in vitro biological activity of 3-phenyl-3-pyrrolylpentane derivatives
XU Meng;GE Zhixin;HAO Meixi;ZHANG Can;Jiangsu Key Laboratory of Drug Discovery for Metabolic Diseases;Center of Drug Discovery;China Pharmaceutical University;
..............page:30-37
Discovery of novel EphB4 inhibitors based on pharmacophore modeling and virtual screening techniques
SHAO Xin;YI Qianying;YANG Chunlei;College of Life Sciences;Sichuan University;College of Chemical Engineering;Sichuan University;
..............page:38-47
Synthesis and antitumor activity of isosteviol derivatives
LIU Yan;WANG Tingting;CHEN Li;Department of Natural Medicinal Chemistry;China Pharmaceutical University;Zhenjiang Institute for Drug Control;
..............page:48-53
Determination of catechin,epicatechin,gallic acid and procyanidin B2 in procyanidins by RP-HPLC
ZHANG Lu;PAN Peipei;CHEN Saizhen;Department of Pharmacy;Taizhou Central Hospital;
..............page:54-57
Identification of related substances in ambrisentan by LC-MS/MS
CHEN Leilin;SONG Min;ZHANG Ge;WANG Lei;HANG Taijun;Department of Pharmaceutical Analysis;China Pharmaceutical University;Jiangsu Jiayi Pharmaceuticals Corporation;
..............page:58-65
Study of interaction between bovine serum albumin and nefopam enantiomers with affinity capillary monolith
ZENG Yu;JI Yibing;Department of Analytical Chemistry;China Pharmaceutical University;
..............page:66-72
Pharmacokinetics of dimemorfan phosphate following single-and multipledose oral administration in healthy Chinese volunteers
YU Xiaxia;FU Jinfeng;ZHAO Hui;TIAN Yuan;ZHANG Zunjian;Ministry of Education Key Laboratory of Drug Quality Control and Pharmacovigilance;China Pharmaceutical University;State Key Laboratory of Natural Medicine;China Pharmaceutical University;
..............page:73-78
Shenmai injection inhibits inflammatory response in lipopolysaccharides-induced septic mice
CHAI Yingying;CAO Lijuan;ZHANG Haowen;CHEN Hanyu;WANG Guangji;HAO Haiping;Key Laboratory of Drug Metabolism and Pharmacokinetics;China Pharmaceutical University;Nanjing University of Chinese Medicine;
..............page:79-83
Effects and mechanism of peroxiredoxin-6 on ultraviolet-induced corneal injury in rats
LYU Jiahui;JIANG Minmin;SHI Hui;LI Jianyuan;DU Zhenning;School of Pharmacy;Yantai University;School of Life Science;Yantai University;Central Laboratory of Yantai Yuhuangding Hospital;
..............page:84-89
Cisplatin inhibits survival of human esophageal squamous carcinoma cells via p53 activation
GU Chunping;Que Fuchang;LI Yilei;LIU Shuwen;YU Le;Department of Pharmacy;Nanfang Hospital;Southern Medical University;School of Pharmaceutical Sciences;Southern Medical University;
..............page:90-94
In vitro study on the regulation of Shengmai San on dysbacteriosis of intestinal flora
HUA Haiying;LI Xueqing;LIU Jihua;Jiangsu Key Laboratory of TCM Evaluation and Translational Research;China Pharmaceutical University;
..............page:95-100
Combination of scFv-AFP with doxorubicin inhibits cell proliferation in hepatocellular carcinoma cell Huh7
SHEN Yanli;JI Xiaonan;GAO Xiangdong;School of Life Science and Technology;China Pharmaceutical University;
..............page:101-105
Condition of human Th17 cell differentiation induced in vitro
WANG Chen;GUO Wei;WANG Xin;YU Dongmei;WANG Yuheng;YAO Wenbing;School of Life Science and Technology;China Pharmaceutical University;
..............page:106-111
Research progress of 1,2-dilinoleyloxy-3-dimethylaminopropane-based cationic lipid nanoparticle
HU Yue;CHEN Zhou;LUO Xiaoxing;XUE Xiaoyan;14~ Company;1~ Student Brigade;The Fourth Military Medical University;Department of Pharmacology;School of Pharmacy;The Fourth Military Medical University;
..............page:112-117
Advances in lipid-lowering effect of PPARα agonists
HU Yue;XU Jun;LIU Yanhua;WANG Zengtao;HUANG Liming;FANG Jialong;WANG Chen;Department of Medicinal Chemistry;Jiangxi University of Traditional Chinese Medicine;
..............page:118-124
zhong shu ke da xue bao tou gao xu zhi
..............page:125-126